Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chifumbe Chintu

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Paediatric and Perinatal Epidemiology|August 17, 2006
Risk factors for subclinical mastitis among HIV-infected and uninfected women in Lusaka, ZambiaLackson Kasonka, Mpundu Makasa, Tom Marshall, et al.
AIDS (London, England)|April 19, 2013
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?Quirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Journal of Tropical Pediatrics|November 13, 2004
Congenital trypanosomiasisMary Shilalukey Ngoma, Mutinta Nalubamba, Sumbukeni Kowa, et al.
AIDS (London, England)|December 7, 2006
Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected childrenVeronica Mulenga, Deborah Ford, A Sarah Walker, et al.
AIDS (London, England)|March 5, 2008
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tabletsRafaëlla F A L'homme, Desiré Kabamba, Fiona M Ewings, et al.
The Pediatric Infectious Disease Journal|May 29, 2010
Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapineRavindra K Gupta, Deborah Ford, Veronica Mulenga, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Plos One|March 4, 2014
Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in ZambiaJeremy S Slone, Catherine Chunda-Liyoka, Marta Perez, et al.
Plos One|May 3, 2011
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effectsJessica E Haberer, Adrian Cook, A Sarah Walker, et al.
AIDS (London, England)|March 22, 2008
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in ZambiaMáirín Ryan, Susan Griffin, Bona Chitah, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Paediatric and Perinatal Epidemiology|August 17, 2006
Risk factors for subclinical mastitis among HIV-infected and uninfected women in Lusaka, ZambiaLackson Kasonka, Mpundu Makasa, Tom Marshall, et al.
AIDS (London, England)|April 19, 2013
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?Quirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Journal of Tropical Pediatrics|November 13, 2004
Congenital trypanosomiasisMary Shilalukey Ngoma, Mutinta Nalubamba, Sumbukeni Kowa, et al.
AIDS (London, England)|December 7, 2006
Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected childrenVeronica Mulenga, Deborah Ford, A Sarah Walker, et al.
AIDS (London, England)|March 5, 2008
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tabletsRafaëlla F A L'homme, Desiré Kabamba, Fiona M Ewings, et al.
The Pediatric Infectious Disease Journal|May 29, 2010
Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapineRavindra K Gupta, Deborah Ford, Veronica Mulenga, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Plos One|March 4, 2014
Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in ZambiaJeremy S Slone, Catherine Chunda-Liyoka, Marta Perez, et al.
Plos One|May 3, 2011
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effectsJessica E Haberer, Adrian Cook, A Sarah Walker, et al.
AIDS (London, England)|March 22, 2008
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in ZambiaMáirín Ryan, Susan Griffin, Bona Chitah, et al.
Pageof 4